ReachMD

Harold Bays, MD. FNLA, is Board Certified in Endocrinology and Internal Medicine. Dr. Bays has served as an Investigator for over 400 Phase I - IV clinical trials regarding treatments for dyslipidemias, obesity, diabetes mellitus, hypertension, and other metabolic and hormonal disorders.

As Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center, Dr. Bays has written, or served as a contributing author to over 200 published scientific manuscripts and book chapters, as well as over 100 scientific abstracts presented at major scientific meetings. He is a Fellow of the National Lipid Association (FNLA), Fellow of The Obesity Society (FTOS), and Fellow of the American Association of Clinical Endocrinologists (FACE). He has served as an advisor/consultant to pharmaceutical companies regarding drug development, protocol writing, statistical analyses, regulatory application, FDA Advisory panel presentations, and patent assistance. Dr. Bays originated the term "adiposopathy" ("sick fat"), which defines how and when the pathologic consequences of adipose tissue accumulation promotes metabolic disease, including dyslipidemia, diabetes mellitus, and hypertension.

Dr. Bays is a co-author of the National Lipid Association Recommendations for Patient-Centered Treatment of Dyslipidemia and coauthor of the American Society of Bariatric Physician Obesity Algorithm. He was Chairman of the National Lipid Association 2012 Adiposity and Dyslipidemia Consensus Conference; and Chairman of the 2010 American Association of Clinical Endocrinologist Adipose Tissue Pathophysiology State of the Science Conference.